Brightgene Bio-medical Technology Co (SHSE:688166) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 11, 2026)


SHSE:688166 Brightgene Bio-medical Technology Co Ltd SHSE:688166
84 GF Score
Price ¥31.19
GF Value ¥38.49
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Brightgene Bio-medical Technology Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Brightgene Bio-medical Technology Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688166 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brightgene Bio-medical Technology Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Brightgene Bio-medical Technology Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688166
84GF Score
Brightgene Bio-medical Technology Co Ltd SHSE:688166
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?

Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued. The current stock price of ¥31.19 is trading 19% below its estimated GF Value™ of ¥38.49. GuruFocus considers Brightgene Bio-medical Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688166:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥38.49 vs. price of ¥31.19 (19% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Brightgene Bio-medical Technology Co Business Description

Address No. 218 Xinghu Street, Buildings C25-C28, Nanotechnology Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215123
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
84GF Score

Get the complete analysis for SHSE:688166

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.19
Price
¥38.49
GF Value